GPGI heads into next month's earnings event as one of the most contested setups in its peer group — a sharp post-earnings sell-off, a short interest surge, and a cluster of insiders buying into the slide are all pulling in different directions at once.
The dominant story this week is how fast short sellers rebuilt positions after the May 7 earnings print. SI % FF jumped from roughly 12% to 15.4% in a single session on May 8, and has held near that level ever since, closing the latest reading at 15.2% of the free float. That's a 26% increase over the week — short interest is back to levels last seen in early April, when the stock was trading around $18–19. The reset matters: shorts had spent most of April covering, driving SI below 12% by late April. They reversed that entire unwind in two days.
Options positioning corroborates the shift in tone, though in an unusual direction. The put/call ratio has collapsed to 0.108 — nearly 2.6 standard deviations below its 20-day average of 0.17. That's close to its 52-week low of 0.039. Heavy call-side activity at these levels typically reflects short-term bounce hunters and speculative buyers rather than directional bears adding puts. It sets up an interesting divergence: the share-lending market is adding shorts while the options market is stacked with calls. Borrow costs remain subdued at 0.80% APR, with availability running above 100% of short interest — meaning there are still roughly as many shares available to lend as are already borrowed, leaving the lending market far from squeezed.
The Street has quietly downgraded its expectations. JP Morgan moved yesterday — still Neutral, but the price target came down hard from $22 to $15, acknowledging the damage done by the May 7 earnings drop. That $15 target essentially tracks where the stock is now ($12.10). The mean analyst target across coverage remains $22, though that figure is partly anchored by stale estimates; at current prices, the implied upside is large on paper but the JP Morgan cut is the freshest signal. The ORTEX short score sits at 74.6 — near the top of its recent range and in the 99th percentile of the universe — confirming that the data-driven short case ranks as one of the stronger setups available right now. Valuation has compressed materially: the P/E has fallen roughly 3.5 turns over the past month to 12.1x, and P/B has shed more than two turns to 5.9x. The EV/EBITDA multiple at 8.2x is the one figure still drifting higher, reflecting the EBITDA base eroding more slowly than the equity price.
Insiders are fighting back. Director Rebecca Corbin Loree bought roughly 4,000 shares at $12.87 on May 12 — a small transaction, but notable as a fresh signal at the current depressed level. That follows a much larger cluster in January, when five directors including Joseph DeAngelo put up a combined $8.75 million at $18.50 per share. Those January buyers are sitting on losses of around 35%. This week's fresh purchase from Loree adds to a 90-day net insider buy of approximately $1.2 million across 70,000 shares — a consistent directional signal, if not a large one in absolute terms. Separately, Starboard Value was disclosed as increasing its stake to just over 5 million shares, adding another institutional name to the growing list of contrarian holders.
The earnings history underscores why shorts are not yet deterred. The May 7 report produced a 20.5% single-day decline and a 28.9% drop over the subsequent five sessions — the kind of reaction that emboldens bears heading into the next print. That next event is scheduled for June 4. With SI near a recent high, options skewed to calls, a JP Morgan target cut still fresh, and a stock that has already lost 28% in a month, the June 4 date is the clearest near-term reference point for which side of this tug-of-war is proved right.
See the live data behind this article on ORTEX.
Open GPGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
